{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:32:16Z","timestamp":1775273536542,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0206600"],"award-info":[{"award-number":["2016YFC0206600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jtha.2024.09.032","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:53:40Z","timestamp":1729511620000},"page":"222-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Xinyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ancai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4204-686X","authenticated-orcid":false,"given":"Yuquan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.09.032_bib1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2014from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2024.09.032_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/ATVBAHA.122.318884","article-title":"Elevated LDL cholesterol increases microvascular endothelial VWF and thromboinflammation after myocardial infarction","volume":"43","author":"Ozawa","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.09.032_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","article-title":"Coronary microvascular obstruction in acute myocardial infarction","volume":"37","author":"Niccoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.09.032_bib4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.09.032_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/1570161115666170201114835","article-title":"Von Willebrand factor and cardiovascular disease: from a biochemical marker to an attractive therapeutic target","volume":"15","author":"Gragnano","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jtha.2024.09.032_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jacc.2018.12.045","article-title":"von Willebrand factor and management of heart valve disease: JACC review topic of the week","volume":"73","author":"Van Belle","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib7","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.3390\/ijms22084200","article-title":"VWF, platelets and the antiphospholipid syndrome","volume":"18","author":"Huang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.09.032_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-bioeng-071516-044539","article-title":"Thrombus formation at high shear rates","volume":"19","author":"Casa","year":"2017","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.jtha.2024.09.032_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"(Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2024.09.032_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cell.2020.10.005","article-title":"Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques","volume":"183","author":"Aid","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2024.09.032_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.007913","article-title":"Molecular imaging of VWF (von Willebrand factor) and platelet adhesion in postischemic impaired microvascular reflow","volume":"11","author":"Ozawa","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jtha.2024.09.032_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2013-07-514992","article-title":"VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice","volume":"123","author":"Savchenko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.09.032_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5620314","article-title":"The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy","volume":"2017","author":"Gragnano","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jtha.2024.09.032_bib14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s12272-012-1000-3","article-title":"Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an anti-vWF aptamer, against thrombotic risk","volume":"35","author":"Bae","year":"2012","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jtha.2024.09.032_bib15","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1021\/acs.chemrev.0c01140","article-title":"Aptamer-based detection of circulating targets for precision medicine","volume":"121","author":"Wu","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtha.2024.09.032_bib16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/bab.2244","article-title":"SELEX: critical factors and optimization strategies for successful aptamer selection","volume":"69","author":"Kohlberger","year":"2022","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.jtha.2024.09.032_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.thromres.2014.05.021","article-title":"Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status","volume":"134","author":"Li","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.09.032_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/jth.14755","article-title":"The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer","volume":"18","author":"Zhu","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.09.032_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68125-9","article-title":"The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin","volume":"10","author":"Kovacevic","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.09.032_bib20","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/s41598-021-82747-7","article-title":"The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients","volume":"11","author":"Kovacevic","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.09.032_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1055\/s-0040-1713888","article-title":"von Willebrand factor predicts mortality in ACS patients treated with potent P2Y12 antagonists and is inhibited by aptamer BT200 ex\u00a0vivo","volume":"120","author":"Kovacevic","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.09.032_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.2022016571","article-title":"The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A","volume":"141","author":"Ay","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.09.032_bib23","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1182\/bloodadvances.2022007805","article-title":"The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF\/FVIII in type 2B von Willebrand disease","volume":"6","author":"Ay","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.09.032_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112589","article-title":"The influence of light on the beat rate variability of murine embryonic stem cell derived cardiomyocytes","volume":"146","author":"Niehoff","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtha.2024.09.032_bib25","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.jacc.2022.03.370","article-title":"Disruption of circadian rhythms by shift work exacerbates reperfusion injury in myocardial infarction","volume":"79","author":"Zhao","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib26","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3390\/pharmaceutics14122781","article-title":"Artificial base-directed in\u00a0vivo formulation of aptamer-drug conjugates with albumin for long circulation and targeted delivery","volume":"14","author":"Sun","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtha.2024.09.032_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1296","article-title":"BMP6 knockdown enhances cardiac fibrosis in a mouse myocardial infarction model by upregulating AP-1\/CEMIP expression","volume":"13","author":"Lu","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jtha.2024.09.032_bib28","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2012-06-440255","article-title":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.09.032_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00109-018-1691-0","article-title":"NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression","volume":"96","author":"Li","year":"2018","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jtha.2024.09.032_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yjmcc.2022.01.006","article-title":"The nuclear receptor co-repressor 1 is a novel cardioprotective factor against acute myocardial ischemia-reperfusion injury","volume":"166","author":"Qin","year":"2022","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102288","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPK\u03b11\/ULK1\/FUNDC1\/mitophagy pathway","volume":"52","author":"Cai","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.jtha.2024.09.032_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (proprotein convertase subtilisin\/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.09.032_bib33","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/eurheartj\/ehac109","article-title":"Circadian nuclear receptor Rev-erb\u03b1 is expressed by platelets and potentiates platelet activation and thrombus formation","volume":"43","author":"Shi","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.09.032_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/859073","article-title":"Intramyocardial hemorrhage: an enigma for cardiac MRI?","volume":"2015","author":"Calvieri","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jtha.2024.09.032_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacc.2021.11.002","article-title":"Intramyocardial hemorrhage: the final frontier for preventing heart failure post-myocardial infarction","volume":"79","author":"Berry","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV\u00a0remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"Hamirani","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jtha.2024.09.032_bib38","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.immuni.2023.05.007","article-title":"Multi-omics blood atlas reveals\u00a0unique features of immune and platelet responses to SARS-CoV-2 omicron breakthrough infection","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2024.09.032_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"van der Meijden","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib40","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/med.21579","article-title":"Bioactive peptides and proteins as alternative antiplatelet drugs","volume":"39","author":"Rengasamy","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jtha.2024.09.032_bib41","article-title":"Identification of immune-related genes in acute myocardial infarction based on integrated bioinformatical methods and experimental verification","volume":"11","author":"Liu","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.jtha.2024.09.032_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","article-title":"A\u00a0double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jtha.2024.09.032_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00395-022-00930-x","article-title":"Blunting TRPML1 channels protects myocardial ischemia\/reperfusion injury by restoring impaired cardiomyocyte autophagy","volume":"117","author":"Xing","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jtha.2024.09.032_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12929-023-00927-1","article-title":"Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia\/reperfusion injury by interacting with NAMPT","volume":"30","author":"Ju","year":"2023","journal-title":"J\u00a0Biomed Sci"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T02:40:28Z","timestamp":1767235228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624006147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1538783624006147"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.09.032","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}